Why the DEA just approved a cannabis drug for rare childhood form of epilepsy

www.cnbc.com
Date:
Thursday, Sep 27, 2018

Amanda Reuther ran into the room where her husband was with their infant daughter, Paeyton, when she heard him yell, "She's choking!" Paeyton's arms and legs were twitching in unison, and her eyes rolled back into her head as the skin of her face turned a dull gray color.

That was Paeyton's first seizure when she was one-year-old, and it was the beginning of a four-year-long odyssey of doctor visits, medications, sudden seizures, hospitalizations and near constant worry and helplessness for their family. This June, Paeyton, who is now six, began taking CBD oil after she had 11 seizures in 10 hours.

The only CBD drug that's been approved so far is for two forms of childhood epilepsy. On Thursday the Drug Enforcement Agency approved GW Pharmaceuticals' antiseizure drug, derived from cannabis. The FDA approved the CBD drug back in June.

Source: GW Pharmaceuticals GW Pharmaceuticals cannabis laboratory

There are about 400 chemical compounds found in marijuana, also known as cannabis. The main active ingredient is THC, which is psychoactive, while the second is CBD, which is not. The hope is that CBD can provide all or many of the well-documented health benefits of marijuana without getting people high, but epilepsy is the only approved-use case.

Source: Amanda Reuther Amanda Reuther and her daughter Paeyton Reuther, who suffers from a rare form of childhood epilepsy. The Reuther family turned to a cannabis-derived oil when conventional epilepsy medications failed to control her seizures. Paeyton has not had a seizure since she started using CBD.   show chapters

Advertisement
Advertisement